bearish
Junshi Bioscience (君实医药) IPO: Early in Application but Behind in Key Indications (Part 1)
465 Views12 Nov 2018 09:54
Shanghai Junshi Biosciences, a China-based biotechnology company listed on the NEEQ market (ticker 833330.NEEQ) with a market capitalization of USD...
SUMMARY
(Sign Up to Access)Get started on the Smartkarma Research Network with a complimentary Preview Pass to:
- Unlock all research summaries
- Follow top, independent analysts
- Receive personalised alerts and emails
- Access Briefings, Analytics, and Events
Upgrade anytime to our paid plans for full-length research, real-time analyst discussions, and more.
Join a thriving community of 45,000+ investors, including the top global asset managers managing over $13trn in assets.
or
Already have an account? Sign In Now
Full Insight
(Paid Plans Only, 11-minute read)
Discussions
(Paid Plans Only)
Price Chart(Sign Up to Access)
- Junshi Bioscience Lock-Up Expiry: Valuation Still Rich with Few R&D Updates24 Jun 2019
- Junshi Bioscience (君实医药) IPO: Rich Valuation, but Catalyst Ahead11 Dec 2018
- Junshi Bioscience (君实医药) IPO: Thoughts on Valuation (Part 2)03 Dec 2018
- Junshi Bioscience (君实医药) IPO: Early in Application but Behind in Key Indications (Part 1)12 Nov 2018
- Innovent Biologics (信达生物) IPO: Pricing the PD-1 and Biosimilars Competition (Part 2)10 Oct 2018
- Innovent Biologics (信达生物) IPO: A Major PD-1 MAb Competitor Might Have Just Emerged (Part 1)13 Sep 2018
x